pubmed-article:19380569 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:19380569 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:19380569 | lifeskim:mentions | umls-concept:C0021079 | lld:lifeskim |
pubmed-article:19380569 | lifeskim:mentions | umls-concept:C1522577 | lld:lifeskim |
pubmed-article:19380569 | lifeskim:mentions | umls-concept:C0867389 | lld:lifeskim |
pubmed-article:19380569 | lifeskim:mentions | umls-concept:C0024485 | lld:lifeskim |
pubmed-article:19380569 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:19380569 | pubmed:dateCreated | 2009-4-21 | lld:pubmed |
pubmed-article:19380569 | pubmed:abstractText | OBJECTIVE: The purpose of this study was to use MRI and physical examination to assess the evolution of disabling musculocutaneous changes induced by chronic graft-versus-host disease in patients receiving immunosuppressive therapy. CONCLUSION: MRI monitoring appears to yield accurate information about the extent and activity of musculocutaneous abnormalities related to chronic graft-versus-host disease during immunosuppressive therapy. | lld:pubmed |
pubmed-article:19380569 | pubmed:language | eng | lld:pubmed |
pubmed-article:19380569 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19380569 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:19380569 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19380569 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19380569 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:19380569 | pubmed:month | May | lld:pubmed |
pubmed-article:19380569 | pubmed:issn | 1546-3141 | lld:pubmed |
pubmed-article:19380569 | pubmed:author | pubmed-author:ClaussenClaus... | lld:pubmed |
pubmed-article:19380569 | pubmed:author | pubmed-author:BossAndreasA | lld:pubmed |
pubmed-article:19380569 | pubmed:author | pubmed-author:VogelWichardW | lld:pubmed |
pubmed-article:19380569 | pubmed:author | pubmed-author:HorgerMariusM | lld:pubmed |
pubmed-article:19380569 | pubmed:author | pubmed-author:FenchelMichae... | lld:pubmed |
pubmed-article:19380569 | pubmed:author | pubmed-author:SchmalzingMar... | lld:pubmed |
pubmed-article:19380569 | pubmed:author | pubmed-author:BethgeWolfgan... | lld:pubmed |
pubmed-article:19380569 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:19380569 | pubmed:volume | 192 | lld:pubmed |
pubmed-article:19380569 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:19380569 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:19380569 | pubmed:pagination | 1401-6 | lld:pubmed |
pubmed-article:19380569 | pubmed:meshHeading | pubmed-meshheading:19380569... | lld:pubmed |
pubmed-article:19380569 | pubmed:meshHeading | pubmed-meshheading:19380569... | lld:pubmed |
pubmed-article:19380569 | pubmed:meshHeading | pubmed-meshheading:19380569... | lld:pubmed |
pubmed-article:19380569 | pubmed:meshHeading | pubmed-meshheading:19380569... | lld:pubmed |
pubmed-article:19380569 | pubmed:meshHeading | pubmed-meshheading:19380569... | lld:pubmed |
pubmed-article:19380569 | pubmed:meshHeading | pubmed-meshheading:19380569... | lld:pubmed |
pubmed-article:19380569 | pubmed:meshHeading | pubmed-meshheading:19380569... | lld:pubmed |
pubmed-article:19380569 | pubmed:meshHeading | pubmed-meshheading:19380569... | lld:pubmed |
pubmed-article:19380569 | pubmed:meshHeading | pubmed-meshheading:19380569... | lld:pubmed |
pubmed-article:19380569 | pubmed:meshHeading | pubmed-meshheading:19380569... | lld:pubmed |
pubmed-article:19380569 | pubmed:meshHeading | pubmed-meshheading:19380569... | lld:pubmed |
pubmed-article:19380569 | pubmed:meshHeading | pubmed-meshheading:19380569... | lld:pubmed |
pubmed-article:19380569 | pubmed:meshHeading | pubmed-meshheading:19380569... | lld:pubmed |
pubmed-article:19380569 | pubmed:meshHeading | pubmed-meshheading:19380569... | lld:pubmed |
pubmed-article:19380569 | pubmed:meshHeading | pubmed-meshheading:19380569... | lld:pubmed |
pubmed-article:19380569 | pubmed:meshHeading | pubmed-meshheading:19380569... | lld:pubmed |
pubmed-article:19380569 | pubmed:meshHeading | pubmed-meshheading:19380569... | lld:pubmed |
pubmed-article:19380569 | pubmed:year | 2009 | lld:pubmed |
pubmed-article:19380569 | pubmed:articleTitle | Musculocutaneous chronic graft-versus-host disease: MRI follow-up of patients undergoing immunosuppressive therapy. | lld:pubmed |
pubmed-article:19380569 | pubmed:affiliation | Department of Diagnostic Radiology, Eberhard-Karls-University, Hoppe-Seyler-Strasse 3, Tübingen, Germany. mshorger@med.uni-tuebingen.de | lld:pubmed |
pubmed-article:19380569 | pubmed:publicationType | Journal Article | lld:pubmed |